This is a multiple site, randomized, double blinded parallel-group controlled study. The purpose of this study is to evaluate efficacy, safety, and tolerability of repeated, daily sessions with the STARSTIM device, which delivers transcranial cathodal direct current stimulation (tDCS). Subjects will be treated with STARTSTIM or sham device for 10 sessions over a 2-week period. The subjects will be followed for an additional 10 weeks post treatment. Quality of Life questionnaires and adverse events will be collected and evaluated.
Conditions
- Refractory Epilepsy
- Focal Seizure
- Seizures, Focal
- Seizures
- Epilepsy in Children
- Epilepsy
- Epilepsy, Tonic-Clonic
Intervention
- STARSTIM device
- Sham Device
Principal Investigator
- Bannout, Firas
Sponsor
- Neuroelectrics Corporation
*The source of data for this particular study is "ClinicalTrials.gov" and was last updated on 05/16/2024. Loma Linda University does not make any warranties, expressed or implied, with respect to such data, and, furthermore, assumes no liability for any party's use, or the results of such use of the data.
Request Information
Complete the form below to contact the study team and receive more information about this trial.